ezetimibe has been researched along with Idiopathic Inflammatory Myopathies in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Emerson, A; Gonski, P | 1 |
Ballantyne, CM; Brennan, DM; Bruckert, E; Ceška, R; Dent-Acosta, RE; Elliott, M; Gouni-Berthold, I; Lehman, SJ; Lepor, N; Nissen, SE; Preiss, D; Rosenson, RS; Sattar, N; Scott, R; Somaratne, R; Stein, EA; Stroes, E; Wasserman, SM | 1 |
Brosteaux, C; Buclin, T; Kuntzer, T; Rodondi, N; Ruiz, J | 1 |
1 review(s) available for ezetimibe and Idiopathic Inflammatory Myopathies
Article | Year |
---|---|
[Statins and muscular side-effects].
Topics: Age Factors; Aged, 80 and over; Algorithms; Anticholesteremic Agents; Azetidines; Biopsy; Cardiovascular Diseases; Creatine Kinase; Ezetimibe; Female; Humans; Life Style; Male; Muscle, Skeletal; Muscular Diseases; Myositis; Pain; Primary Prevention; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyolysis; Secondary Prevention; Sex Factors; Ubiquinone | 2010 |
1 trial(s) available for ezetimibe and Idiopathic Inflammatory Myopathies
Article | Year |
---|---|
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholesterol, LDL; Creatine Kinase; Cross-Over Studies; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; Myalgia; Myositis; Rhabdomyolysis; Time Factors | 2016 |
1 other study(ies) available for ezetimibe and Idiopathic Inflammatory Myopathies
Article | Year |
---|---|
Polypharmacy induced myositis.
Topics: Aged, 80 and over; Clarithromycin; Drug Interactions; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myositis; Polypharmacy; Pregabalin; Simvastatin | 2020 |